Cite
The frequency of thyroid incidental findings and risk of malignancy detected by 68Ga-labeled prostate-specific membrane antigen PET/CT in prostate cancer.
MLA
Gossili, Farid, et al. “The Frequency of Thyroid Incidental Findings and Risk of Malignancy Detected by 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Prostate Cancer.” Hellenic Journal of Nuclear Medicine, vol. 23, no. 3, Sept. 2020, pp. 240–45. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=148015304&authtype=sso&custid=ns315887.
APA
Gossili, F., Petersen, L. J., & Zacho, H. D. (2020). The frequency of thyroid incidental findings and risk of malignancy detected by 68Ga-labeled prostate-specific membrane antigen PET/CT in prostate cancer. Hellenic Journal of Nuclear Medicine, 23(3), 240–245.
Chicago
Gossili, Farid, Lars J. Petersen, and Helle D. Zacho. 2020. “The Frequency of Thyroid Incidental Findings and Risk of Malignancy Detected by 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Prostate Cancer.” Hellenic Journal of Nuclear Medicine 23 (3): 240–45. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=148015304&authtype=sso&custid=ns315887.